ELEVATE, a Registry of Patients With Acute Hepatic Porphyria (AHP)

Clinical trial NCT04883905 · RECRUITING

Trial details

NCT number: NCT04883905
Sponsor: Alnylam Pharmaceuticals
Status: RECRUITING
Study type: OBSERVATIONAL

Acute Hepatic Porphyria

Start date: 2021-04-26
Primary completion: 2027-04-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.